benign vocal fold lesion
Conditions
Interventions
None listed
Sponsors
International University of Health and Welfare
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Patients who have undergone intravocal steroid injection therapy since April 1, 2014
Exclusion criteria
Exclusion criteria: Patients with non-participation statement
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Voice Handicap Index 3-4 months after injection | — |
Secondary
| Measure | Time frame |
|---|---|
| maximum phonation time, mean airflow rate, GRBAS scale | — |
Countries
Japan
Contacts
Public ContactTakeharu Kanazawa
International University of Health and Welfare Tokyo Voice Center
Outcome results
None listed